Allergy Tablet, Film Coated
NDC Package 41226-692-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Allergy (cetirizine hydrochloride) tablets is uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nosesneezingitchy, watery eyesitching of the nose or throat. This formulation utilizes a tablet, film coated delivery system. Marketed by Kroger Company, this product is identified by NDC 41226-692 and is authorized under FDA application ANDA078933.

Identification & Billing

NDC Package Code
41226-692-14
Package Description
2 BOTTLE in 1 CARTON / 70 TABLET, FILM COATED in 1 BOTTLE
Product Code
41226-692
11-Digit Billing Format
41226069214
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Allergy
Non-Proprietary Name
Cetirizine Hydrochloride
Substance Name
Cetirizine Hydrochloride
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CETIRIZINE HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nosesneezingitchy, watery eyesitching of the nose or throat

Regulatory & Marketing

Labeler Name
Kroger Company
Product Type
Human Otc Drug
FDA Application #
ANDA078933
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-11-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (41226-692). Click a package code to view its specific billing and regulatory data.

41226-692-65
1 BOTTLE in 1 CARTON / 365 TABLET, FILM COATED in 1 BOTTLE
41226-692-70
1 BOTTLE in 1 CARTON / 70 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 41226-692-14 identifies a specific commercial package of 2 bottle in 1 carton / 70 tablet, film coated in 1 bottle of Allergy, a human over the counter drug labeled by Kroger Company. This tablet, film coated is formulated for oral use and contains cetirizine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kroger Company on May 11, 2021. The current certification is valid through December 31, 2026.

How is this Kroger Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 41226069214. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
41226-692-14
11-Digit CMS (5-4-2)
41226-0692-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.